Genmab | GJELD

Debt Endring Dato
Agios Pharmaceuticals USD 68.35M 67.21M 2024-03
Almirall EUR 352.3M 50.95M 2024-03
Amarin USD 8.39M 8.39M 2024-03
Amgen USD 64.02B 593M 2024-03
AstraZeneca USD 34.55B 5.93B 2024-03
Bayer EUR 45.01B 2.42B 2023-12
BioMarin Pharmaceutical USD 1.1B 9.56M 2024-03
Demant DKK 14.45B 44M 2023-12
Exelixis USD 201.47M 201.47M 2024-03
Fresenius Medical Care EUR 12.03B 943.85M 2024-03
Galapagos EUR 7.98M 1.62M 2024-03
Genmab DKK 1.01B 240M 2024-03
GlaxoSmithKline GBP 17.77B 246M 2024-03
GN Store Nord DKK 12.59B 911M 2024-03
GRIFOLS EUR 10.12B 939.25M 2023-12
Hikma Pharmaceutical USD 1.19B 121M 2023-12
Insmed USD 1.21B 25.76M 2024-03
Lonza CHF 2.8B 109M 2023-12
Merck EUR 9.95B 13M 2024-03
Novartis USD 27.28B 936M 2024-03
Regeneron Pharmaceuticals USD 2.7B 400K 2024-03
Roche Holding CHF 29.21B 3.82B 2023-12
UCB EUR 3.04B 142M 2023-12



Genmab GJELD - Gjeldende verdier, historiske data, prognoser, statistikk, diagrammer og økonomiske kalender - Jun 2024.